We're getting healthier. We're living longer. There are people to thank for that, and we're proud to support them
Despite general concerns over health issues such as obesity, life expectancy in the UK continues to rise. Ever more sophisticated pharmaceutical treatments to alleviate heart problems, lower cholesterol and stabilise blood pressure are major contributory factors. Thanks to effective immunisation our children are suffering fewer infections during childhood, and better nutrition will help them grow taller and stronger. Breakthroughs are continuous; only this week the work of Florida University Pharmaceutics Professor Mandip Sachdeva led to the first ever 3D print of a human cornea, paving the way for treatments including eye transplants. Such advances are contributing to a longevity and quality of life for our children that would previously have been confined to the pages of science fiction.
And our children are growing up. Huge numbers of those born at the turn of the century are now economically active. They are smart, capable and ambitious. And they are also candidates for the 22nd century.
Research indicates that children born around the dawn of the 21st century have a one in four chance of living to see the 22nd. These children of the Millennium will live to see beyond the horizon.
The medical advancements that shape their lives are becoming more and more widely available. The life sciences sector supports almost half a million jobs in the UK alone. Industry leaders are looking to new partnerships in Asia and Africa. Although it currently accounts for only around 2% of the global pharmaceutical market, demand in the Middle East and North Africa is growing rapidly. Since 2005, healthcare spending in the region has been rising at an average annual rate of 15%. Forecasts have the value of the MENA pharma market reaching $40 billion by 2021 and $60 billion by 2025.
The MENA region’s healthcare systems don’t yet have a tried and tested mechanism for providing universally accessible healthcare of suitable cost and quality. The good news is that many pharma suppliers are tailoring their service to the best possible ad-hoc care, focusing on the shipment of smaller, targeted orders to give customers exactly what they need, exactly when they need it. Better, faster critical patient care meets economic needs and more to the point, saves lives.
None of this can happen, of course, without effective clinical trials. Studies in safety and efficacy are painstaking, with accurate communication between clinicians and patients at a premium.
In the first half of 2019, Conversis has successfully completed translation projects to and from 167 languages, and we’ve earned our status as the language service partner of choice for this sector.
Conversis Sales Director Debbie Pell sees this process from start to finish:
“I’m proud to be part of a team that supports pharma blue chips and contract research organisations. You can’t put a price on the importance of clear, sensitive communication that breaks down linguistic and cultural barriers. and it’s gratifying to see the results. My children have long lives ahead of them, and those lives will be enhanced by the pioneering work of our life sciences partners. My first message to those partners is that they can always rely on Conversis to deliver their translations to the highest professional standard. My second message is, quite simply, thank you”
At the dawn of the twentieth century, serious consideration was given to closing the UK patent office. It was widely believed that everything worth inventing had been invented. Anyone who has ever watched a TV programme, booked a flight or marvelled at our ability to send manned missions to the Moon will be relieved that we didn’t draw a line under human ingenuity while Queen Victoria was still on the British throne. Babies born in this new century will live to see a world unrecognisable from our own. Technological advances will no doubt astonish them as they continue to astonish us, and medical advances will maintain their health and well-being in ways we can’t yet anticipate. But one thing will remain constant. If you want to care for the world, safeguard the world and add value to the world the one thing you have to do first is speak to the world. We’re here to help you do that.
To find out more, or to get a free quote, contact us today.